The Randomized Controlled Trial for Evaluating the Efficacies of Tolvaptan in Patients with ascites in hepatic edema

Trial Profile

The Randomized Controlled Trial for Evaluating the Efficacies of Tolvaptan in Patients with ascites in hepatic edema

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Sep 2016

At a glance

  • Drugs Tolvaptan (Primary) ; Furosemide
  • Indications Ascites; Liver cirrhosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Aug 2016 Status changed from recruiting to completed.
    • 27 Apr 2015 Planned End Date changed to 10 Mar 2016 as reported by UMIN record.
    • 30 Sep 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top